Notification of Transactions of Directors, Persons Discharging
Managerial Responsibility or Connected Persons
The Administrators of the GlaxoSmithKline Annual Investment Plan notified the Company and the under-mentioned Director of the exercise of the following awards on 15 March 2013 at a price of 1495 pence per share.
Director
|
Date of Award |
Number of Ordinary Shares exercised |
Dr M M Slaoui
|
20 March 2003 |
5,143 |
20 March 2004 |
5,228 |
|
18 March 2005 |
5,393 |
|
20 March 2006 |
10,217 |
|
Total |
25,981 |
11,715 Ordinary Shares were then sold to cover tax obligations on 18 March 2013 at a price of 1495.50 pence per share.
The Company and the above-mentioned Director were advised of this information by the Administrators of the Plan on 18 March 2013.
This notification relates to a transaction notified in accordance with Disclosure and Transparency Rule 3.1.4R(1)(a).
V A Whyte
Company Secretary
19 March 2013